AOD-9604

AOD-9604 is a modified fragment of human growth hormone (HGH fragment 176-191). It was developed to have the fat-reducing effects of growth hormone without the adverse effects on blood sugar or growth.

Mechanism of Action

Stimulates lipolysis (fat breakdown) and inhibits lipogenesis (fat accumulation) without affecting blood sugar or growth. Works specifically on adipose tissue through a mechanism independent of GH receptors.

Typical Dosage (Research)

Research dosing typically ranges from 250-500mcg daily, often split into morning and afternoon doses. Some protocols use higher doses up to 1mg.

Subcutaneous injection, typically in the abdominal area. Best administered on an empty stomach. Can be combined with exercise for enhanced effects.

Side Effects & Risks

Generally well-tolerated. May cause headaches, injection site reactions, or temporary lethargy. Does not affect blood glucose like full GH.

Limited long-term human data. Failed to receive FDA approval as an anti-obesity drug. Quality and purity concerns with research-grade products.

Who Uses AOD-9604

Those seeking targeted fat loss, athletes and bodybuilders during cutting phases, individuals wanting GH fat-loss benefits without muscle growth effects.